Total homocysteine as a risk factor for vascular disease in renal transplant recipient

被引：0
|
作者：
Juskowa, J [1 ]
Paczek, L [1 ]
Markiewicz, D [1 ]
Bartlomiejczyk, I [1 ]
Matuszewicz, D [1 ]
Sadowska, A [1 ]
机构：
[1] Univ Warsaw, Sch Med, Inst Transplantat, Dept Immunotherapy & Internal Dis, Warsaw, Poland
来源：
EUROPEAN HEART JOURNAL | 2000年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1563
引用
收藏
页码：276 / 276
页数：1
相关论文
共 50 条
  • [21] POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD) IN A RENAL TRANSPLANT RECIPIENT
    Gupta, Aarti
    Panda, Deepanjan
    Ahuja, Arvind
    Thulkar, Sanjay
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (04) : 38 - 38
  • [22] Homocysteine and the brain: vascular risk factor or neurotoxin?
    Seshadri, S
    Wolf, PA
    LANCET NEUROLOGY, 2003, 2 (01): : 11 - 11
  • [23] RISK FACTOR-ANALYSIS IN RENAL-TRANSPLANTATION - GUIDELINES FOR MANAGEMENT OF TRANSPLANT RECIPIENT
    FINKELSTEIN, FO
    BLACK, HR
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1974, 267 (03): : 159 - 169
  • [24] Homocysteine -: A treatable risk factor for allograft vascular disease after heart transplantation?
    Kutschka, I
    Pethig, K
    Strüber, M
    Dieterich, C
    Harringer, W
    Haverich, A
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (07): : 743 - 746
  • [25] Homocysteine: A treatable risk factor for allograft vascular disease after heart transplantation
    Kutschka, I
    Pethig, K
    Strueber, M
    Dieterich, C
    Haverich, A
    CIRCULATION, 1999, 100 (18) : 163 - 163
  • [26] Plasma homocysteine as a risk factor for vascular disease - The European concerted action project
    Graham, IM
    Daly, LE
    Refsum, HM
    Robinson, K
    Brattstrom, LE
    Ueland, PM
    PalmaReis, RJ
    Boers, GHJ
    Sheahan, RG
    Israelsson, B
    Uiterwaal, CS
    Meleady, R
    McMaster, D
    Verhoef, P
    Witteman, J
    Rubba, P
    Bellet, H
    Wautrecht, JC
    deValk, HW
    Luis, ACS
    ParrotRoulaud, FM
    Tan, KS
    Higgins, I
    Garcon, D
    Medrano, MJ
    Candito, M
    Evans, AE
    Andria, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22): : 1775 - 1781
  • [27] AN UNUSUAL MISPLACEMENT OF A FEMORAL VASCULAR CATHETER IN A RENAL TRANSPLANT RECIPIENT
    Khor, Candice
    Ng, Zhuo Lin
    Wong, Jeffrey
    NEPHROLOGY, 2022, 27 : 100 - 100
  • [28] TOTAL HIP-REPLACEMENT IN THE RENAL-TRANSPLANT RECIPIENT
    RADFORD, PJ
    DORAN, A
    GREATOREX, RA
    RUSHTON, N
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1989, 71 (03): : 456 - 459
  • [29] Characteristics of extracoronary vascular disease in heart transplant recipient
    Takayama, Hiroo
    Salerno, Christopher T.
    Aldea, Gabriel S.
    Verrier, Edward D.
    JOURNAL OF CARDIAC SURGERY, 2008, 23 (05) : 459 - 463
  • [30] Homocysteine: "Expensive creatinine" or important, modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients?
    Bostom, AG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2000, 11 (01): : 149 - 151
12345